148 related articles for article (PubMed ID: 2064418)
1. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
[TBL] [Abstract][Full Text] [Related]
2. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
3. Dysplastic nevi and other risk markers for melanoma.
Seykora J; Elder D
Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
[TBL] [Abstract][Full Text] [Related]
4. Dysplastic nevi in association with multiple primary melanoma.
Titus-Ernstoff L; Duray PH; Ernstoff MS; Barnhill RL; Horn PL; Kirkwood JM
Cancer Res; 1988 Feb; 48(4):1016-8. PubMed ID: 3338073
[TBL] [Abstract][Full Text] [Related]
5. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
[TBL] [Abstract][Full Text] [Related]
7. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Goldstein AM; Martinez M; Tucker MA; Demenais F
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
[TBL] [Abstract][Full Text] [Related]
8. Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation.
Hartge P; Holly EA; Halpern A; Sagebiel R; Guerry D; Elder D; Clark W; Hanson L; Harrison C; Tarone R
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):37-40. PubMed ID: 7894322
[TBL] [Abstract][Full Text] [Related]
9. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period.
Barnhill RL; Kiryu H; Sober AJ; Mihm MC
Arch Dermatol; 1990 Apr; 126(4):463-5. PubMed ID: 2321991
[TBL] [Abstract][Full Text] [Related]
10. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
11. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital.
Duray PH; Ernstoff MS
Arch Dermatol; 1987 Jan; 123(1):80-4. PubMed ID: 3800426
[TBL] [Abstract][Full Text] [Related]
12. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
[TBL] [Abstract][Full Text] [Related]
13. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis.
Weis E; Shah CP; Lajous M; Shields JA; Shields CL
Ophthalmology; 2009 Mar; 116(3):536-543.e2. PubMed ID: 19167086
[TBL] [Abstract][Full Text] [Related]
14. Use of host factors to identify people at high risk for cutaneous malignant melanoma .
Marrett LD; King WD; Walter SD; From L
CMAJ; 1992 Aug; 147(4):445-53. PubMed ID: 1498755
[TBL] [Abstract][Full Text] [Related]
15. Grading of atypia in nevi: correlation with melanoma risk.
Arumi-Uria M; McNutt NS; Finnerty B
Mod Pathol; 2003 Aug; 16(8):764-71. PubMed ID: 12920220
[TBL] [Abstract][Full Text] [Related]
16. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
Tucker MA; Halpern A; Holly EA; Hartge P; Elder DE; Sagebiel RW; Guerry D; Clark WH
JAMA; 1997 May; 277(18):1439-44. PubMed ID: 9145715
[TBL] [Abstract][Full Text] [Related]
17. Smoking, sun exposure, number of nevi and previous neoplasias are risk factors for melanoma in older patients (60 years and over).
Nagore E; Hueso L; Botella-Estrada R; Alfaro-Rubio A; Serna I; Guallar J; González I; Ribes I; Guillen C
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):50-7. PubMed ID: 19563496
[TBL] [Abstract][Full Text] [Related]
18. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
19. Are atypical nevi a risk factor for uveal melanoma? A case-control study.
van Hees CL; de Boer A; Jager MJ; Bleeker JC; Kakebeeke HM; Crijns MB; Vandenbroucke JP; Bergman W
J Invest Dermatol; 1994 Aug; 103(2):202-5. PubMed ID: 8040610
[TBL] [Abstract][Full Text] [Related]
20. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
